In addition to the kinase group enrichment, for each set of results (i.e., all samples, high purity, BRAF mutants, etc.)we looked for BP enrichment among significant genes, as a hypothesis-free approach to further characterize the metastatic tumors (S4 Table). This evidence concerns the gene BRAF and metastatic neoplasm.